Enlivex Therapeutics Ltd. News, Enlivex Therapeutics Ltd. Quote, ENLV Quote

Enlivex Therapeutics Ltd. (NQ:ENLV) Delayed: 0.62 --0 (-0%)

Prev. Close

$0.62

Today 6M 1Y 5Y

Open

$0.64

52 Wk High

$0.94

52 Wk Low

$0.47

Day High

$0.65

Day Low

$0.61

P/E

N/A

EPS

$-0.11

Volume

323,677

Friends, Peers and Foes (?): BIAF, ASPI, BFRG, GRRR, NVA (more...)

ALERTS | RSS

Jun 15, 2026 08:03 AM Enlivex receives Australian patent for Allocetra osteoarthritis treatment
Jun 15, 2026 08:00 AM Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Jun 2, 2026 08:00 AM ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026
Jun 1, 2026 08:00 AM Enlivex to present Allocetra knee osteoarthritis data at EULAR congress
Jun 1, 2026 08:00 AM Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
May 28, 2026 08:05 AM Form 6-K Enlivex Ltd. For: May 28
May 28, 2026 08:01 AM Enlivex reports $1.16 billion RAIN token holdings as of May 27
May 28, 2026 08:00 AM Enlivex reports $1.16 billion RAIN token holdings value
May 28, 2026 08:00 AM Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
May 27, 2026 08:05 AM Form 6-K Enlivex Ltd. For: May 27

Entities mentioned with ENLV

View All Entities